| Dr Vanessa Elharrar, MD | |
|
7878 Seville Pl Apt 2502, Boca Raton, FL 33433-6327 | |
| (202) 870-7785 | |
| Not Available |
| Full Name | Dr Vanessa Elharrar |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 7878 Seville Pl Apt 2502, Boca Raton, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558792085 | NPI | - | NPPES |
| 01060513A | Other | IN | INDIANA MEDICAL LICENSING BOARD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | 01060513A (Indiana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vanessa Elharrar, MD 7878 Seville Pl Apt 2502, Boca Raton, FL 33433-6327 Ph: (202) 870-7785 | Dr Vanessa Elharrar, MD 7878 Seville Pl Apt 2502, Boca Raton, FL 33433-6327 Ph: (202) 870-7785 |
News Archive
Arteriocyte, Inc., was honored Friday by the Ohio Venture Association as a Venture of Year Award Finalist. Founded in 2004 to develop proprietary stem cell and tissue engineering based therapies, Arteriocyte focuses on developing commercially available stem cell based therapies using multiple sources of adult derived stem cells (marrow, peripheral cord blood, and cartilage) for delivery to injured tissues in order to speed repair and improve function.
The American Cancer Society and the Clinton Health Access Initiative (CHAI) today announced agreements with pharmaceutical companies Pfizer, Novartis, and Mylan to expand access to 20 lifesaving cancer treatments in 26 countries in sub-Saharan Africa and Asia. Purchasers are expected to save an average of 59 percent for medicines procured through the agreements.
Gilead Sciences, Inc. today announced that the company's Marketing Authorisation Application for sofosbuvir, a once-daily oral nucleotide analogue inhibitor for the treatment of chronic hepatitis C virus infection, which was submitted to the European Medicines Agency on April 17, 2013, has been fully validated and is now under assessment.
Solazyme, Inc., a renewable oil and bioproducts company, announced today financial results for the first quarter ended March 31, 2012 and recent key corporate highlights.
University of Toronto researchers have shown that "designer molecules" can interact with the body's insulin receptor, a step toward the development of an oral medication for diabetes. U of T professors Lakshmi Kotra, Cecil Yip, Peter Ottensmeyer and Robert Batey have created the first small molecules using the three-dimensional structure of the insulin receptor. A receptor is the site on the surface of a cell to which molecules with specific tasks, such as hormones, attach themselves. Insulin's task is to initiate the utilization of sugar in the blood.
› Verified 2 days ago
Mr. Jared Ross Zipper, LCSW Preventive Medicine Medicare: Accepting Medicare Assignments Practice Location: 6405 Congress Ave Ste 160, Boca Raton, FL 33487 Phone: 561-464-5500 Fax: 561-464-5501 | |
Mario Jacomino, MD, MPH Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Glades Rd # Bc-71, Boca Raton, FL 33431 Phone: 561-297-0723 | |
Nia Marina Smyrniotis, MD Preventive Medicine Medicare: Medicare Enrolled Practice Location: 5295 Town Center Rd, Suite # 201, Boca Raton, FL 33486 Phone: 561-288-3520 | |
Rachel Leeann Lewis, LAT, ATC Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Glades Rd, Boca Raton, FL 33431 Phone: 561-297-1056 | |
Charles H Hennekens, M.D. Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: Florida Atlantic University, 777 Glades Rd., Boca Raton, FL 33431 Phone: 561-297-4074 | |
Craig John Robinson Wilder, ATC Preventive Medicine Medicare: Not Enrolled in Medicare Practice Location: 777 Glades Rd, Boca Raton, FL 33431 Phone: 561-297-2044 Fax: 561-297-0468 |